Does SUNITINIB MALATE Cause Malignant neoplasm progression? 178 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 178 reports of Malignant neoplasm progression have been filed in association with SUNITINIB MALATE (Sunitinib malate). This represents 0.8% of all adverse event reports for SUNITINIB MALATE.
178
Reports of Malignant neoplasm progression with SUNITINIB MALATE
0.8%
of all SUNITINIB MALATE reports
66
Deaths
53
Hospitalizations
How Dangerous Is Malignant neoplasm progression From SUNITINIB MALATE?
Of the 178 reports, 66 (37.1%) resulted in death, 53 (29.8%) required hospitalization, and 9 (5.1%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for SUNITINIB MALATE. However, 178 reports have been filed with the FAERS database.
What Other Side Effects Does SUNITINIB MALATE Cause?
Death (4,385)
Diarrhoea (3,044)
Fatigue (2,865)
Nausea (2,032)
Neoplasm progression (1,920)
Disease progression (1,745)
Decreased appetite (1,676)
Asthenia (1,651)
Vomiting (1,331)
Dysgeusia (1,226)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which SUNITINIB MALATE Alternatives Have Lower Malignant neoplasm progression Risk?
SUNITINIB MALATE vs SUTENT
SUNITINIB MALATE vs SUTIMLIMAB-JOME
SUNITINIB MALATE vs SUVOREXANT
SUNITINIB MALATE vs SUZETRIGINE
SUNITINIB MALATE vs SYMBICORT